Skip to main content

Peer Review reports

From: Linezolid dose adjustment according to therapeutic drug monitoring helps reach the goal concentration in severe patients, and the oldest seniors benefit more

Original Submission
12 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
20 Jul 2023 Reviewed Reviewer Report
24 Jul 2023 Reviewed Reviewer Report - Yoshio Takesue
30 Aug 2023 Author responded Author comments - Chen Qu
Resubmission - Version 4
30 Aug 2023 Submitted Manuscript version 4
31 Aug 2023 Author responded Author comments - Chen Qu
Resubmission - Version 5
31 Aug 2023 Submitted Manuscript version 5
11 Sep 2023 Reviewed Reviewer Report - Yoshio Takesue
27 Sep 2023 Reviewed Reviewer Report
29 Oct 2023 Author responded Author comments - Chen Qu
Resubmission - Version 6
29 Oct 2023 Submitted Manuscript version 6
1 Nov 2023 Reviewed Reviewer Report - Yoshio Takesue
15 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
17 Nov 2023 Editorially accepted
29 Nov 2023 Article published 10.1186/s12879-023-08831-7

You can find further information about peer review here.

Back to article page